Medinotec (MDNC) Income from Continuing Operations (2022 - 2026)
Medinotec (MDNC) reported Income from Continuing Operations of 466647.0 for Q1 2026, down 120.56% on a YoY basis from 2269466.0 in Q1 2025, and down 168.81% quarter-over-quarter from 678155.0 in Q4 2025.
Medinotec (MDNC) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Medinotec has reported Income from Continuing Operations for 5 years, with the latest figure at 466647.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 120.56% year-over-year to 466647.0; the trailing twelve-month figure through Feb 2026 stood at 668172.0 (down 77.44% YoY), and the FY2026 full-year result was 1467890.0, down 60.98% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 466647.0, down from 678155.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2269466.0 in Q1 2025, with the low at 492371.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 174434.76 across 5 years, with a median of 21961.0 in 2022.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 2342.02% — and 2024, when it surged 768.46%.
- Medinotec's Income from Continuing Operations stood at 21961.0 in 2022, then slumped by 2342.02% to 492371.0 in 2023, then soared by 163.02% to 310311.0 in 2024, then jumped by 118.54% to 678155.0 in 2025, then tumbled by 168.81% to 466647.0 in 2026.
- The last three Income from Continuing Operations figures came in at 466647.0 (Q1 2026), 678155.0 (Q4 2025), and 342880.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Medinotec | - | - | 854,557.00 | -466,647.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -466,647.00 |
| Nov 30, 2025 | 678,155.00 |
| Aug 31, 2025 | 342,880.00 |
| May 31, 2025 | 113,784.00 |
| Feb 28, 2025 | 2.27 Mn |
| Nov 30, 2024 | 310,311.00 |
| Aug 31, 2024 | 294,348.00 |
| May 31, 2024 | 87,204.00 |
| Feb 29, 2024 | 330,676.00 |
| Nov 30, 2023 | -492,371.00 |
| Aug 31, 2023 | -44,034.00 |
| May 31, 2023 | 18,350.00 |
| Feb 28, 2023 | -71,495.00 |
| Nov 30, 2022 | 21,961.00 |
| Aug 31, 2022 | -219,294.00 |
| May 31, 2022 | -83,904.00 |
| Feb 28, 2022 | -123,999.00 |